BOBO DONALD E JR 4
4 · Edwards Lifesciences Corp · Filed Dec 10, 2025
Insider Transaction Report
Form 4
BOBO DONALD E JR
CVP,Strategy/Corp Development
Transactions
- Exercise/Conversion
Common Stock
2025-12-10$59.26/sh+11,340$671,971→ 61,696.371 total - Sale
Common Stock
2025-12-10$83.83/sh−11,340$950,581→ 50,356.371 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2025-12-10−11,340→ 45,360 totalExercise: $59.26From: 2019-06-08Exp: 2026-05-07→ Common Stock (11,340 underlying)
Holdings
- 38,817.699(indirect: By 401(k))
Common Stock
- 135,152(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $83.465 to $84.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.